Abstract:Endometriosis is a common gynecologic disorder with an enigmatic etiopathogenesis. Although it has been proposed that endometriosis is a hormonal disease, an autoimmune disease, a genetic disease, and a disease caused by exposure to environmental toxins, our understanding of its etiopathogenesis is still inadequate, as reflected by recent apparent setbacks in clinical trials on endometriosis. In the last 5 years, evidence has emerged that endometriosis may be an epigenetic disease. In this article, the evidence in support of this hypothesis is reviewed, and its diagnostic, therapeutic and prognostic implications discussed. Publications, up to the end of June 2009, pertaining to epigenetic aberration in endometriosis were identified through PubMed. In addition, publications on related studies were also retrieved and reviewed. Epigenetics appears to be a common denominator for hormonal and immunological aberrations in endometriosis. Epigenetics also appears to have a better explanatory power than genetics. There is accumulating evidence that various epigenetic aberrations exist in endometriosis. In vitro studies show that histone deacetylase inhibitors may be promising therapeutics for treating endometriosis. In conclusion, several lines of evidence suggest that epigenetics plays a definite role in the pathogenesis and pathophysiology of endometriosis. As such, endometriosis is possibly treatable by rectifying epigenetic aberrations through pharmacological means. DNA methylation markers may also be useful for diagnostic and prognostic purposes. It is also possible that the delineation of the epigenetic changes accompanied by the genesis and progression of endometriosis could lead to interventions that reduce the risk of developing endometriosis.

[Research Progress on Epigenetics in Endometriosis].

Progress in Research on Epigenetics of Endometriosis-Associated Infertility

[Research progress on the role of epithelial-mesenchymal transition in pathogenesis of endometriosis].

The Epigenetics of Endometriosis

Epigenetics of Estrogen and Progesterone Receptors in Endometriosis

Apoptosis and Endometriosis

Endometriosis and Cell Migration

[Research Progress on Oxidative Stress in Pathogenesis of Endometriosis].

Endometriosis Malignant Transformation: Epigenetics as a Probable Mechanism in Ovarian Tumorigenesis

Recent insights on the genetics and epigenetics of endometriosis

Aberrant DNA methylation status of endometriosis: Epigenetics as the pathogenesis, biomarker and therapeutic target

Epigenetic dysregulation of endometriosis susceptibility genes (Review).

The roles of chromatin regulatory factors in endometriosis

Epigenetic Disorder May Cause Downregulation of HOXA10 in the Eutopic Endometrium of Fertile Women with Endometriosis.

Genetic, Epigenetic, and Steroidogenic Modulation Mechanisms in Endometriosis

Endometriosis-associated infertility and pelvic environment and epigenetic

Epigenetic Dynamics of HOXA10 Gene in Infertile Women With Endometriosis

Estrogen Biosynthesis and Its Regulation in Endometriosis

The role of miR-34c-5p/Notch in epithelial-mesenchymal transition (EMT) in endometriosis

The DNA methylation status of genes encoding Matrix metalloproteinases and tissue inhibitors of Matrix metalloproteinases in endometriosis.

Role of Oxidative Stress in Epigenetic Modification in Endometriosis